Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol

BACKGROUND: Both the number and size of tumours in NF1 patients increase in response to the rise in steroid hormones seen at puberty and during pregnancy. The size of tumours decreases after delivery, suggesting that hormone-targeting therapy might provide a viable new NF1 treatment approach. Our ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yu-chi, Upadhyayula, Ravi, Cevallos, Stephanie, Messick, Ryan J, Hsia, Tammy, Leese, Mathew P, Jewett, Douglas M, Ferrer-Torres, Daysha, Roth, Therese M, Dohle, Wolfgang, Potter, Barry V L, Barald, Kate F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647869/
https://www.ncbi.nlm.nih.gov/pubmed/26461061
http://dx.doi.org/10.1038/bjc.2015.345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647869/
https://www.ncbi.nlm.nih.gov/pubmed/26461061
http://dx.doi.org/10.1038/bjc.2015.345

Ejemplares similares